Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Older diabetes patients with high stress levels are more likely to experience memory loss

Researchers at the University of Edinburgh studied more than 900 men and women aged between 60 and 75 with type-2 diabetes, which tends to be common after the age of 40.

23 Feb 2010

Excessive weight gain during pregnancy linked to increased risk of gestational diabetes

Women who gain excessive weight during pregnancy, especially in the first trimester, may increase their risk of developing diabetes later in their pregnancy, according to a study by the Kaiser Permanente Division of Research that appears online in the current issue of Obstetrics and Gynecology.

23 Feb 2010

Senate, FDA reports increasing concerns about controversial diabetes drug

"Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market ... ," The New York Times reports. "The internal F.D.A. reports are part of a fierce debate within the agency over what to do about Avandia, manufactured by GlaxoSmithKline."

23 Feb 2010

Children born through assisted reproduction at greater risk of obesity and type 2 diabetes related defects

More than three million children have been born as a result of assisted reproductive technologies since the birth of the first "test tube baby" in 1978. While the majority of these children are healthy and normal, as a group they are at greater risk of certain kinds of birth defects and being low birth weight, which is associated with obesity, hypertension and type 2 diabetes later in life.

22 Feb 2010

Pharmaceutical and biotechnology companies working on nearly 200 new medicines to treat diabetes

A Stratton Spotlight article recently highlighted a Centers for Disease Control and Prevention (CDC) survey that showed a dramatic rise in the number of diabetes cases during the last 10 years and noted that pharmaceutical research and biotechnology companies are working on nearly 200 new medicines to treat this debilitating disease.

19 Feb 2010

New resource for parents to combat childhood obesity

In October 2009, two national non-profit organizations teamed together to launch a free resource for parents to help them combat childhood obesity in their homes and communities.

19 Feb 2010

Lower dose of avosentan drug may provide more favorable results in diabetes patients

The drug avosentan substantially reduces urinary protein loss in people with type 2 diabetes and kidney disease, but the drug causes serious side effects, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

18 Feb 2010

Norwegian government task force suggests formation of single company to commercialise biomaterial assets

Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country’s various sources. The task force has also recommended HUNT Biosciences be a model for the national company.

18 Feb 2010

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.

17 Feb 2010

StayWell Consumer Health Publishing to feature consumer health information in Pathway Genomics Genetic Health Report

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company today announced an agreement with StayWell Consumer Health Publishing to feature a robust suite of consumer health information in Pathway’s Genetic Health Reports.

17 Feb 2010

RWJF awards nearly $2M in grants to address childhood obesity epidemic

Seven organizations representing policy-makers from across the country have received a total of nearly $2 million in grants from the Robert Wood Johnson Foundation (RWJF) to help communities increase children's access to affordable healthy foods and opportunities for physical activity.

17 Feb 2010

Merck announces global sales of $27.4 billion for full-year 2009

Merck & Co., Inc. today announced financial results for the fourth quarter and the full year of 2009 which include the results of legacy Schering-Plough operations from the close of the merger on Nov. 3, 2009 through Dec. 31, 2009.

16 Feb 2010

Studies show association between high levels of vitamin D and decreased risk of heart disease

Middle aged and elderly people with high levels of vitamin D could reduce their chances of developing heart disease or diabetes by 43%, according to researchers at the University of Warwick.

16 Feb 2010

When blood sugar levels rise in healthy people, insulin signals cells to increase production: Study

In type 2 diabetes, which is occurring at alarming rates, the hormone insulin does not work effectively to lower blood sugars and patients also do not make enough insulin. These two processes have been widely considered as separate.

16 Feb 2010

Researchers use $1.3M grant from NIH to study on obesity and Type 2 diabetes

A team of Northern Arizona University-led researchers is using nearly $1.3 million in new funding from the National Institutes of Health to continue with the world's longest-running study on obesity and Type 2 diabetes.

15 Feb 2010

Simplex Healthcare to implement comprehensive wellness program for employees

Simplex Healthcare today announced that it is partnering with Onlife Health, a national personal health coaching company, to implement a comprehensive wellness program for its more than 300 employees.

15 Feb 2010

Diabetic retinopathy: 5.3M U.S adults suffer

Despite major progress in diagnosis and treatment, diabetic retinopathy remains the major cause of blindness in adults under 60 in the U.S., said Thomas C. Lee, director, Retina Institute in The Vision Center at Childrens Hospital Los Angeles, associate professor of clinical ophthalmology at the Keck School of Medicine of the University of Southern California and attending physician at Doheny Eye Institute.

12 Feb 2010

White rye flour bread leads to better insulin and blood sugar levels than wheat bread with rye bran

Wholegrain bread is good and good for you, as most people know. But it is not only the fiber-rich bran, the outer shell of the grain, that is healthful. On the contrary, research at the Lund University Faculty of Engineering shows that bread baked with white rye flour, which is flour made from the inner, white part of the rye kernel, leads to better insulin and blood sugar levels compared with wheat bread with rye bran. White rye flour thus leads to much better values than both regular wheat flour and rye bran. At the same time, much of the bread that is sold in stores today in most countries is in fact baked with wheat flour and bran from various grains.

12 Feb 2010

Researchers develop dietary supplement to offset key symptom of ageing

Researchers at McMaster University have developed a cocktail of ingredients that forestalls major aspects of the aging process.

12 Feb 2010

Ethnic and racial minorities less likely to receive A1C diabetes test

Ethnic and racial minorities bear a disproportionate share of America's diabetes epidemic but are significantly less likely than whites to receive a commonly used test to monitor control of blood glucose, according to Washington State University researchers.

12 Feb 2010

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Older diabetes patients with high stress levels are more likely to experience memory loss

Excessive weight gain during pregnancy linked to increased risk of gestational diabetes

Senate, FDA reports increasing concerns about controversial diabetes drug

Children born through assisted reproduction at greater risk of obesity and type 2 diabetes related defects

Pharmaceutical and biotechnology companies working on nearly 200 new medicines to treat diabetes

New resource for parents to combat childhood obesity

Lower dose of avosentan drug may provide more favorable results in diabetes patients

Norwegian government task force suggests formation of single company to commercialise biomaterial assets

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

StayWell Consumer Health Publishing to feature consumer health information in Pathway Genomics Genetic Health Report

RWJF awards nearly $2M in grants to address childhood obesity epidemic

Merck announces global sales of $27.4 billion for full-year 2009

Studies show association between high levels of vitamin D and decreased risk of heart disease

When blood sugar levels rise in healthy people, insulin signals cells to increase production: Study

Researchers use $1.3M grant from NIH to study on obesity and Type 2 diabetes

Simplex Healthcare to implement comprehensive wellness program for employees

Diabetic retinopathy: 5.3M U.S adults suffer

White rye flour bread leads to better insulin and blood sugar levels than wheat bread with rye bran

Researchers develop dietary supplement to offset key symptom of ageing

Ethnic and racial minorities less likely to receive A1C diabetes test

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in